Edition:
India

Five Prime Therapeutics Submits Investigational New Drug Application For FPA150


Thursday, 4 Jan 2018 

Jan 3 (Reuters) - Five Prime Therapeutics Inc ::FIVE PRIME THERAPEUTICS SUBMITS INVESTIGATIONAL NEW DRUG APPLICATION FOR NOVEL B7-H4 ANTIBODY FPA150.FIVE PRIME THERAPEUTICS INC - ANTICIPATES INITIATING A PHASE 1 TRIAL OF FPA150 DURING FIRST HALF OF 2018. 

Company Quote

5.87
0.0 +0.00%
26 Jun 2019